Top Markets
#1 Beta Finance Beta Finance +49.20%
#2 Janction Janction +21.70%
#3 Resolv RLP Resolv RLP +15.55%
#4 Siren Siren +12.72%
#5 ZetaChain ZetaChain +7.42%
#6 SmarDex SmarDex +7.33%
#7 Grass Grass +6.36%
#8 Turbo Turbo +6.33%
#9 WAR WAR +6.27%
#10 Comedian Comedian +5.79%
Coin of the day
Beta Finance Beta Finance
Settings
Language
ENGLISH
Currency
USD
Theme
Sanofi Sanofi

Sanofi

SNY
Rank in Stocks #178
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Share Price
$44.60
Market Cap
$108.62B
Change (1 day)
-1.63%
Change (1 year)
-21.62%
Country
FR
Trade Sanofi (SNY)

Category

Healthcare
Number of shares outstanding for Sanofi (SNY)
Number of shares outstanding as of December 2025: 2.44B
According to Sanofi latest financial reports and stock price the company's current number of shares outstanding is 2.44B. At the end of December 2024 the company had 2.50B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Sanofi (SNY) from 2000 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 2.44B 0.00%
2025 2.44B -2.48%
2024 2.50B -0.02%
2023 2.50B -0.02%
2022 2.50B -0.05%
2021 2.51B -0.09%
2020 2.51B 0.30%
2019 2.50B 0.22%
2018 2.49B -0.78%
2017 2.51B -2.31%
2016 2.57B -1.50%
2015 2.61B -0.73%
2014 2.63B -0.55%
2013 2.65B 0.27%
2012 2.64B -0.17%
2011 2.64B 1.26%
2010 2.61B -0.09%
2009 2.61B -0.22%
2008 2.62B -2.79%
2007 2.69B 0.01%
2006 2.69B 0.77%
2005 2.67B 46.82%
2004 1.82B 29.53%
2003 1.41B -3.43%
2002 1.46B -0.55%
2001 1.46B 0.07%
2000 1.46B 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 898.00M -63.21%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
 3.10B 27.01%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.43B -0.50%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.78B -27.06%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 1.91B -21.62%
CH